Publikationen 2021

Inhibition of LIM kinase reduces contraction and proliferation in bladder smooth muscle.
Acta Pharm Sin B 2021; 11(7): 1914-1930;
Yu Q, Wu C, Chen Y, Li B, Wang R, Huang R, Li X, Gu D, Wang X, Duan X, Li S, Liu Y, Wu W, Hennenberg M, Zeng G

[Female urology].
Aktuelle Urol 2021; 52(3): 235-236;
Kranz J, Bauer RM

[The role of the microbiome in urological diseases].
Aktuelle Urol 2021;
Atzler M, Westhofen T, Tamalunas A, Schott M, Keller P, Ebner B, Stief C, Magistro G

The decidual expression of Interleukin-7 is upregulated in early pregnancy loss.
Am J Reprod Immunol 2021;
Vilsmaier T, Amann N, Löb S, Schmoeckel E, Kuhn C, Zati Zehni A, Meister S, Beyer S, Kolben TM, Becker J, Mumm JN, Mahner S, Jeschke U, Kolben T

Impact of antiangiogenic treatment on the erectile function in patients with advanced renal cell carcinoma.
Andrologia 2021; 53(1):e13881
Marcon J, Trottmann M, Rodler S, Becker AJ, Stief CG, Bauer RM, Casuscelli J

Phosphoproteomics identifies potential downstream targets of the integrin α2β1 inhibitor BTT-3033 in prostate stromal cells.
Ann Transl Med 2021; 9(17):
Li B, Li P, Xia W, You B, Yu Q, Zhang B, Huang R, Wang R, Liu Y, Chen Z, Gan Y, He Y, Hennenberg M, Stief CG, Chen X

Interleukin 15 and Eotaxin correlate with the outcome of breast cancer patients vice versa independent of CTC status.
Arch Gynecol Obstet 2021; 303(1): 217-230;
Vilsmaier T, Heidegger HH, Schröder L, Trapp E, Zehni AZ, Rack B, Janni W, Mahner S, Weissenbacher T, Jeschke U, Mumm JN, SUCCESS Study Group

Diagnostic and Prognostic Role of miR-192 in Different Cancers: A Systematic Review and Meta-Analysis.
Biomed Res Int 2021:8851035;
Wang L, Liu Y, Lyu C, Buchner A, Pohla H

A real-world comparison of docetaxel versus abiraterone acetate for metastatic hormone-sensitive prostate cancer.
Cancer Med 2021; 10(18): 6354-6364;
Tsaur I, Heidegger I, Bektic J, Kafka M, van den Bergh RCN, Hunting JCB, Thomas A, Brandt MP, Höfner T, Debedde E, Thibault C, Ermacora P, Zattoni F, Foti S, Kretschmer A, Ploussard G, Rodler S, von Amsberg G, Tilki D, Surcel C, Rosenzweig B, Gadot M, Gandaglia G, Dotzauer R, EAU-YAU Prostate Cancer Working Party

Therapeutic and prognostic implications of NOTCH and MAPK signaling in bladder cancer.
Cancer Sci 2021;
Schulz GB, Elezkurtaj S, Börding T, Schmidt EM, Elmasry M, Stief CG, Kirchner T, Karl A, Horst D

Health-Related Quality of Life following Cytoreductive Radical Prostatectomy in Patients with De-Novo Oligometastatic Prostate Cancer.
Cancers (Basel) 2021; 13(22)
Chaloupka M, Stoermer L, Apfelbeck M, Buchner A, Wenter V, Stief CG, Westhofen T, Kretschmer A

Interstitial Photodynamic Therapy Using 5-ALA for Malignant Glioma Recurrences.
Cancers (Basel) 2021; 13(8):
Lietke S, Schmutzer M, Schwartz C, Weller J, Siller S, Aumiller M, Heckl C, Forbrig R, Niyazi M, Egensperger R, Stepp H, Sroka R, Tonn JC, Rühm A, Thon N

Safety and Efficacy of Robotic Radiosurgery for Visceral and Lymph Node Metastases of Renal Cell Carcinoma: A Retrospective, Single Center Analysis.
Cancers (Basel) 2021; 13(4):
Rodler S, Schott M, Tamalunas A, Marcon J, Graser A, Mumm JN, Casuscelli J, Stief CG, Fürweger C, Muacevic A, Staehler M

Thrombospondin-2 and LDH Are Putative Predictive Biomarkers for Treatment with Everolimus in Second-Line Metastatic Clear Cell Renal Cell Carcinoma (MARC-2 Study).
Cancers (Basel) 2021; 13(11);
Zeuschner P, Hölters S, Stöckle M, Seliger B, Mueller A, Bachmann HS, Grünwald V, Christoph DC, Stenzl A, Grimm MO, Brüning F, Goebell PJ, Augustin M, Roos F, Harde J, Benz-Rüd I, Staehler M, Junker K

Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU - YAU Prostate Cancer Working Group multi-institutional study.
Cent European J Urol 2021; 74(3): 362-365;
Zattoni F, Marra G, Kretschmer A, Preisser F, Tilki D, Kesch C, Radtke JP, Hoffmann N, Morlacco A, Dal Moro F, Soeterik TFW, van den Bergh RCN, Barletta F, Briganti A, Montorsi F, Gandaglia G

Occurrence of symptomatic lymphocele after open and robot-assisted radical prostatectomy.
Cent European J Urol 2021; 74(3): 341-347;
Magistro G, Tuong-Linh Le D, Westhofen T, Buchner A, Schlenker B, Becker A, Stief CG

The impact of preoperative lower urinary tract symptoms medication on the functional performance of holmium laser enucleation of the prostate.
Cent European J Urol 2021; 74(3): 429-436;
Tamalunas A, Westhofen T, Schott M, Keller P, Atzler M, Stief CG, Magistro G

Characterization of PD-1 and PD-L1 Expression in Papillary Renal Cell Carcinoma: Results of a Large Multicenter Study.
Clin Genitourin Cancer 2021; 19(1): 53-59.e1;
Erlmeier F, Steffens S, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, Ströbel P, Becker F, Wülfing C, Barth P, Stöckle M, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Schrader AJ, Hartmann A, Ivanyi P, (German Network Of Kidney Cancer)

Patients' Perspective on Digital Technologies in Advanced Genitourinary Cancers.
Clin Genitourin Cancer 2021; 19(1): 76-82.e6;
Rodler S, Buchner A, Stief CG, Heinemann V, Staehler M, Casuscelli J

Correlation of an Index-Lesion-Based SPECT Dosimetry Method with Mean Tumor Dose and Clinical Outcome after 177Lu-PSMA-617 Radioligand Therapy.
Diagnostics (Basel) 2021; 11(3):
Völter F, Mittlmeier L, Gosewisch A, Brosch-Lenz J, Gildehaus FJ, Zacherl MJ, Beyer L, Stief CG, Holzgreve A, Rübenthaler J, Cyran CC, Böning G, Bartenstein P, Todica A, Ilhan H

Immature Plasma Cell Myeloma Mimics Metastatic Renal Cell Carcinoma on 18F-PSMA-1007 PET/CT Due to Endothelial PSMA-Expression.
Diagnostics (Basel) 2021; 11(3):
Mittlmeier LM, Ledderose ST, Schott M, Brendel M, Beyer L, Theurich S, Mayr D, Walz C, Kunz WG, Ricke J, Bartenstein P, Ilhan H, Staehler M, Unterrainer M

Structured Reporting in the Characterization of Renal Cysts by Contrast-Enhanced Ultrasound (CEUS) Using the Bosniak Classification System-Improvement of Report Quality and Interdisciplinary Communication.
Diagnostics (Basel) 2021; 11(2):
Schnitzer ML, Sabel L, Schwarze V, Marschner C, Froelich MF, Nuhn P, Falck Y, Nuhn MM, Afat S, Staehler M, Rückel J, Clevert DA, Rübenthaler J, Geyer T

Infrared molecular fingerprinting of blood-based liquid biopsies for the detection of cancer.
Elife 2021; 10():
Huber M, Kepesidis KV, Voronina L, Fleischmann F, Fill E, Hermann J, Koch I, Milger-Kneidinger K, Kolben T, Schulz GB, Jokisch F, Behr J, Harbeck N, Reiser M, Stief C, Krausz F, Zigman M

An unusual case of struma ovarii.
Endocrinol Diabetes Metab Case Rep 2021;
Koehler VF, Keller P, Waldmann E, Schwenk N, Kitzberger C, Schmohl KA, Knösel T, Stief CG, Spitzweg C

Routine application of next-generation sequencing testing in uro-oncology-Are we ready for the next step of personalised medicine?
Eur J Cancer 2021; 146(): 1-10;
Rodler S, Jung A, Greif PA, Rühlmann K, Apfelbeck M, Tamalunas A, Kretschmer A, Schulz GB, Szabados B, Stief C, Heinemann V, Westphalen CB, Casuscelli J

18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results.
Eur J Nucl Med Mol Imaging 2021; 48(6): 2031-2037;
Mittlmeier LM, Unterrainer M, Rodler S, Todica A, Albert NL, Burgard C, Cyran CC, Kunz WG, Ricke J, Bartenstein P, Stief CG, Ilhan H, Staehler M

68Ga-EMP-100 PET/CT-a novel ligand for visualizing c-MET expression in metastatic renal cell carcinoma-first in-human biodistribution and imaging results.
Eur J Nucl Med Mol Imaging 2021; ():
Mittlmeier LM, Todica A, Gildehaus FJ, Unterrainer M, Beyer L, Brendel M, Albert NL, Ledderose ST, Vettermann FJ, Schott M, Rodler S, Marcon J, Ilhan H, Cyran CC, Stief CG, Staehler M, Bartenstein P

Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy.
Eur J Nucl Med Mol Imaging 2021;
Rogowski P, Trapp C, von Bestenbostel R, Eze C, Ganswindt U, Li M, Unterrainer M, Zacherl MJ, Ilhan H, Beyer L, Kretschmer A, Bartenstein P, Stief C, Belka C, Schmidt-Hegemann NS

Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patients.
Eur Respir J 2021; 58(1);
Munker D, Osterman A, Stubbe H, Muenchhoff M, Veit T, Weinberger T, Barnikel M, Mumm JN, Milger K, Khatamzas E, Klauss S, Scherer C, Hellmuth JC, Giessen-Jung C, Zoller M, Herold T, Stecher S, de Toni EN, Schulz C, Kneidinger N, Keppler OT, Behr J, Mayerle J, Munker S

Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate Cancer.
Eur Urol 2021; 79(6): 717-721;
Chu CE, Alshalalfa M, Sjöström M, Zhao SG, Liu Y, Chou J, Herlemann A, Mahal B, Kishan AU, Spratt DE, Cooperberg M, Small E, Wong A, Porten S, Hope TA, Ross AE, Davicioni E, Nguyen P, Karnes RJ, Carroll PR, Schaeffer E, Feng FY

Stereotactic Radiotherapy for Oligoprogressive Disease: A New Frontier in Kidney Cancer.
Eur Urol 2021; 80(6): 701-702;
Siva S, Ost P, Zaorsky N, Staehler M

Digital Real-world Data Suggest Patient Preference for Tadalafil over Sildenafil in Patients with Erectile Dysfunction.
Eur Urol Focus 2021;
von Büren M, Rodler S, Wiesenhütter I, Schröder F, Buchner A, Stief C, Gratzke C, Wülfing C, von Büren J

Health-related Quality of Life in Patients with Advanced Prostate Cancer: A Systematic Review.
Eur Urol Focus 2021; 7(4): 742-751;
Kretschmer A, Ploussard G, Heidegger I, Tsaur I, Borgmann H, Surcel C, Mathieu R, de Visschere P, Valerio M, van den Bergh RCN, Marra G, Thibault C, Ost P, Gandaglia G, Tilki D, EAU-YAU Prostate Cancer Working Party

Reply to Francesco Montorsi, Alessandro Larcher, and Umberto Capitanio's Letter to the Editor re: Rohann J.M. Correa, Alexander V. Louie, Nicholas G. Zaorsky, et al. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Eur Urol Focus. 2019 Jun 24. pii: S2405-4569(19)30157-9. https://doi.org/10.1016/j.euf.2019.06.002. [Epub ahead of print].
Eur Urol Focus 2021; 7(2): 404-405;
Correa RJM, Louie AV, Zaorsky NG, Lehrer EJ, Ellis R, Ponsky L, Kaplan I, Mahadevan A, Chu W, Swaminath A, Hannan R, Onishi H, Teh BS, Muacevic A, Lo SS, Staehler M, Siva S

A Systematic Review of the Emerging Role of Immune Checkpoint Inhibitors in Metastatic Castration-resistant Prostate Cancer: Will Combination Strategies Improve Efficacy?
Eur Urol Oncol 2021; 4(5): 745-754;
Heidegger I, Necchi A, Pircher A, Tsaur I, Marra G, Kasivisvanathan V, Kretschmer A, Mathieu R, Ceci F, van den Bergh RCN, Thibault C, Tilki D, Valerio M, Surcel C, Gandaglia G, EAU-YAU Prostate Cancer Working Party

Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy.
Eur Urol Oncol 2021;
Bravi CA, Droghetti M, Fossati N, Gandaglia G, Suardi N, Mazzone E, Cucchiara V, Scuderi S, Barletta F, Schiavina R, Osmonov D, Juenemann KP, Boeri L, Karnes RJ, Kretschmer A, Buchner A, Stief C, Hiester A, Nini A, Albers P, Devos G, Joniau S, Van Poppel H, Grubmüller B, Shariat SF, Heidenreich A, Pfister D, Tilki D, Graefen M, Gill IS, Mottrie A, Karakiewicz PI, Montorsi F, Briganti A

Incidental Prostate Cancer (cT1a-cT1b) Is a Relevant Clinical and Research Entity and Should Be Fully Discussed in the International Prostate Cancer Guidelines.
Eur Urol Oncol 2021;
Capitanio U, Autorino R, Bandini M, Briganti A, Cheng L, Cooperberg MR, Dehò F, Gallina A, Klotz L, Lane B, Montironi R, Salonia A, Stief C, Tombal B, Montorsi F

Novel Liquid Biomarkers and Innovative Imaging for Kidney Cancer Diagnosis: What Can Be Implemented in Our Practice Today? A Systematic Review of the Literature.
Eur Urol Oncol 2021; 4(1): 22-41;
Campi R, Stewart GD, Staehler M, Dabestani S, Kuczyk MA, Shuch BM, Finelli A, Bex A, Ljungberg B, Capitanio U

Reply to Nicolas Mottet, Olivier Rouviere, and Theodorus H. van der Kwast. Incidental Prostate Cancer: A Real Need for Expansion in Guidelines? Eur Urol Oncol. In press: Incidental Prostate Cancer: An Example of How Important Guidelines Are, Especially When Evidence Is Limited.
Eur Urol Oncol 2021;
Capitanio U, Autorino R, Bandini M, Briganti A, Cheng L, Cooperberg MR, Dehò F, Gallina A, Klotz L, Lane BR, Montironi R, Salonia A, Stief C, Tombal B, Montorsi F

A Multi-Institutional Analysis of Prostate Cancer Patients With or Without 68Ga-PSMA PET/CT Prior to Salvage Radiotherapy of the Prostatic Fossa.
Front Oncol 2021; 11()
Schmidt-Hegemann NS, Zamboglou C, Thamm R, Eze C, Kirste S, Spohn S, Li M, Stief C, Bolenz C, Schultze-Seemann W, Bartenstein P, Prasad V, Ganswindt U, Grosu AL, Belka C, Mayer B, Wiegel T

Feasibility of Different Tumor Delineation Approaches for 18F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients
Front Oncol 2021; 11():
Mittlmeier LM, Brendel M, Beyer L, Albert NL, Todica A, Zacherl MJ, Wenter V, Herlemann A, Kretschmer A, Ledderose ST, Schmidt-Hegemann NS, Kunz WG, Ricke J, Bartenstein P, Ilhan H, Unterrainer M

Patient-Reported and Oncological Outcomes of Salvage Therapies for PSMA-Positive Nodal Recurrent Prostate Cancer: Real-Life Experiences and Implications for Future Trial Design.
Front Oncol 2021; 11();
Kretschmer A, Milow J, Eze C, Buchner A, Li M, Westhofen T, Fuchs F, Rogowski P, Trapp C, Ganswindt U, Zacherl MJ, Beyer L, Wenter V, Bartenstein P, Schlenker B, Stief CG, Belka C, Schmidt-Hegemann NS

Concentration-dependent alpha1-Adrenoceptor Antagonism and Inhibition of Neurogenic Smooth Muscle Contraction by Mirabegron in the Human Prostate.
Front Pharmacol 2021; 12();
Huang R, Liu Y, Ciotkowska A, Tamalunas A, Waidelich R, Strittmatter F, Stief CG, Hennenberg M

Bile Acids, Liver Cirrhosis, and Extrahepatic Vascular Dysfunction.
Front Physiol 2021; 12();
Sauerbruch T, Hennenberg M, Trebicka J, Beuers U

Focal Therapy for Prostate Cancer: Complications and Their Treatment.
Front Surg 2021; 8();
Rakauskas A, Marra G, Heidegger I, Kasivisvanathan V, Kretschmer A, Zattoni F, Preisser F, Tilki D, Tsaur I, van den Bergh R, Kesch C, Ceci F, Fankhauser C, Gandaglia G, Valerio M

Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time?
Front Surg 2021; 8();
Zattoni F, Heidegger I, Kasivisvanathan V, Kretschmer A, Marra G, Magli A, Preisser F, Tilki D, Tsaur I, Valerio M, van den Bergh R, Kesch C, Ceci F, Fankhauser C, Gandaglia G

Radical Prostatectomy: Sequelae in the Course of Time.
Front Surg 2021; 8()
Kesch C, Heidegger I, Kasivisvanathan V, Kretschmer A, Marra G, Preisser F, Tilki D, Tsaur I, Valerio M, van den Bergh RCN, Fankhauser CD, Zattoni F, Gandaglia G

Exploratory analysis of the platelet-to-lymphocyte ratio prognostic value in the adjuvant renal cell cancer setting.
Future Oncol 2021; 17(4): 403-409;
Patel A, Ravaud A, Motzer RJ, Pantuck AJ, Staehler M, Escudier B, Martini JF, Lechuga M, Lin X, George DJ

Dynamics of urinary and respiratory shedding of Severe acute respiratory syndrome virus 2 (SARS-CoV-2) RNA excludes urine as a relevant source of viral transmission.
Infection 2021;
Mumm JN, Ledderose S, Ostermann A, Rudelius M, Hellmuth JC, Münchhoff M, Munker D, Scherer C, Volz Y, Ebner B, Giessen-Jung C, Lampert C, Vilsmaier T, Schneider S, Gapp M, Milger-Kneidinger K, Behr J, von Bergwelt-Baildon M, Keppler OT, Stief C, Magistro G, Staehler M,

Everolimus after failure of one prior VEGF-targeted therapy in metastatic renal cell carcinoma: Final results of the MARC-2 trial.
Int J Cancer 2021; 148(7): 1685-1694;
Staehler M, Stöckle M, Christoph DC, Stenzl A, Potthoff K, Grimm MO, Klein D, Harde J, Brüning F, Goebell PJ, Augustin M, Roos F, Benz-Rüd I, Marschner N, Grünwald V

First-line pazopanib in intermediate- and poor-risk patients with metastatic renal cell carcinoma: Final results of the FLIPPER trial.
Int J Cancer 2021; 148(4): 950-960;
Staehler M, Panic A, Goebell PJ, Merling M, Potthoff K, Herrmann E, de Geeter P, Vannier C, Hogrefe C, Marschner N, Grünwald V

Retrospective evaluation of the impact of non-oncologic chronic drug therapy on the survival in patients with bladder cancer.
Int J Clin Pharm 2021;
Haimerl L, Strobach D, Mannell H, Stief CG, Buchner A, Karl A, Grimm T

Bioenergetic Alterations of Metabolic Redox Coenzymes as NADH, FAD and FMN by Means of Fluorescence Lifetime Imaging Techniques.
Int J Mol Sci 2021; 22(11):
Kalinina S, Freymueller C, Naskar N, von Einem B, Reess K, Sroka R, Rueck A

The Prognostic Impact of Retinoid X Receptor and Thyroid Hormone Receptor alpha in Unifocal vs. Multifocal/Multicentric Breast Cancer.
Int J Mol Sci 2021; 22(2);
Zehni AZ, Batz F, Vattai A, Kaltofen T, Schrader S, Jacob SN, Mumm JN, Heidegger HH, Ditsch N, Mahner S, Jeschke U, Vilsmaier T

Computed-tomography based scoring system predicts outcome for clinical lymph node-positive patients undergoing radical cystectomy.
International brazilian journal of urology 2021; 47();
Eismann L, Rodler S, Tamalunas A, Schulz G, Jokisch F, Volz Y, Pfitzinger P, Schlenker B, Stief C, Solyanik O, Buchner A, Grimm T

Quenched coumarin derivatives as fluorescence lifetime phantoms for NADH and FAD.
J Biophotonics 2021;
Freymüller C, Kalinina S, Rück A, Sroka R, Rühm A

Spectrophotometric evaluation of hemolysis in plasma by quantification of free oxyhemoglobin, methemoglobin, and methemalbumin in presence of bilirubin.
J Biophotonics 2021; 14(5):
Heckl C, Lang A, Rühm A, Sroka R, Duffield T, Vogeser M, Paal M

Implementation of a renal pharmacist consultant service - Information sharing in paper versus digital form.
J Clin Pharm Ther 2021;
Seiberth S, Bauer D, Schönermarck U, Mannell H, Stief C, Hasford J, Strobach D

Superiority of Holmium Laser Enucleation of the Prostate over Transurethral Resection of the Prostate in a Matched-Pair Analysis of Bleeding Complications Under Various Antithrombotic Regimens.
J Endourol 2021; 35(3): 328-334;
Westhofen T, Schott M, Keller P, Tamalunas A, Stief C, Magistro G

First Clinical Results for PSMA-Targeted α-Therapy Using 225Ac-PSMA-I&T in Advanced-mCRPC Patients.
J Nucl Med 2021; 62(5): 669-674;
Zacherl MJ, Gildehaus FJ, Mittlmeier L, Boening G, Gosewisch A, Wenter V, Schmidt-Hegemann NS, Belka C, Kretschmer A, Casuscelli J, Stief CG, Unterrainer M, Bartenstein P, Todica A, Ilhan H

Interleukin-1 beta is significantly upregulated in the decidua of spontaneous and recurrent miscarriage placentas.
J Reprod Immunol 2021; 144();
Löb S, Amann N, Kuhn C, Schmoeckel E, Wöckel A, Zati Zehni A, Kaltofen T, Keckstein S, Mumm JN, Meister S, Kolben T, Mahner S, Jeschke U, Vilsmaier T

Editorial Comment.
J Urol 2021; 205(4);
Stief C

Timing of Radiotherapy after Radical Prostatectomy: Effects on Health-Related Quality of Life.
J Urol 2021;
Westhofen T, Buchner A, Schlenker B, Becker A, Li M, Belka C, Stief CG, Schmidt-Hegemann NS, Kretschmer A

Evaluation of hyperspectral imaging to quantify perfusion changes during the modified Allen test.
Lasers Surg Med 2021;
Linek M, Felicio-Briegel A, Freymüller C, Rühm A, Englhard AS, Sroka R, Volgger V

Lenalidomide and pomalidomide inhibit growth of prostate stromal cells and human prostate smooth muscle contraction.
Life Sci 2021; 281();
Tamalunas A, Sauckel C, Ciotkowska A, Rutz B, Wang R, Huang R, Li B, Stief CG, Gratzke C, Hennenberg M

Holmium laser enucleation of the prostate: A truly size-independent method?
Low Urin Tract Symptoms 2021;
Tamalunas A, Westhofen T, Schott M, Keller P, Atzler M, Stief CG, Magistro G

The clinical value of holmium laser enucleation of the prostate in octogenarians.
Low Urin Tract Symptoms 2021; 13(2): 279-285;
Tamalunas A, Westhofen T, Schott M, Keller P, Atzler M, Stief CG, Magistro G

Prostatakarzinom: Richtige Weichenstellung schon in der Hausarztpraxis!
MMW Fortschr Med 2021; 163(7):
Stief CG

[Advanced prostate cancer - modern therapies, better prognosis?]
MMW Fortschr Med 2021; 163(7): 41-43;
Westhofen T, Chaloupka M, Herlemann A, Todenhöfer T, Stief CG, Kretschmer A

[Phimosis in children].
MMW Fortschr Med 2021; 163(10): 58-59;
Eismann L, Riccabona M, Stief CG, Stredele RJF

[Prostate cancer: Screening, imaging, targeted diagnostics].
MMW Fortschr Med 2021; 163(7): 32-35;
Berg E, Ebner B, Herlemann A, Stief CG, Kretschmer A, Chaloupka M

[Prostate cancer: When to treat, which treatment options by stage?]
MMW Fortschr Med 2021; 163(7): 36-40;
Ebner B, Chaloupka M, Berg E, Stief CG, Kretschmer A, Herlemann A

[Treatment of acute renal colic].
MMW Fortschr Med 2021; 163(3): 56-57;
Eismann L, Stief CG, Chaloupka M

[Urinary incontinence in men: causes, diagnostic steps and treatment options].
MMW Fortschr Med 2021; 163(5): 62-69;
Ziegelmüller B, Bauer RM, Sommer A

ADP ribosylation factor 6 promotes contraction and proliferation, suppresses apoptosis and is specifically inhibited by NAV2729 in prostate stromal cells.
Mol Pharmacol 2021;
Wang R, Schneider S, Keppler OT, Li B, Rutz B, Ciotkowska A, Stief CG, Hennenberg M

Purinergic smooth muscle contractions in the human prostate: estimation of relevance and characterization of different agonists.
Naunyn Schmiedebergs Arch Pharmacol 2021;
Spek A, Li B, Rutz B, Ciotkowska A, Huang R, Liu Y, Wang R, Strittmatter F, Waidelich R, Stief CG, Hennenberg M

Age at surgery is not a prognostic factor for the AdVance-XP male sling efficacy: A post-hoc analysis of a prospective 7-year multicentric study.
Neurourol Urodyn 2021; 40(6): 1616-1624;
Mumm JN, Abrarova B, Schütz J, Klehr B, Rodler S, Vilsmaier T, Gozzi C, Rehder P, May F, Homberg R, Gebhartl P, Stief CG, Buchner A, Bauer RM

Salvage cystectomy and ileal conduit urinary diversion as a last-line option for benign diseases-perioperative safety and postoperative health-related quality of life.
Neurourol Urodyn 2021;
Volz Y, Eismann L, Pfitzinger PL, Jokisch JF, Schulz G, Rodler S, Buchner A, Schlenker B, Stief CG, Kretschmer A

The transient receptor potential A1 ion channel (TRPA1) modifies in vivo autonomous ureter peristalsis in rats.
Neurourol Urodyn 2021; 40(1): 147-157;
Weinhold P, Villa L, Strittmatter F, Gratzke C, Stief CG, Castiglione F, Montorsi F, Hedlund P

Value of Geriatric Assessment in Patients With Genitourinary Carcinoma.
Oncology (Williston Park) 2021; 35(9): 620-627;
Zangl Q, Wirth J, Karl A, Stief C, Zwissler B, Von Dossow V

Improving patient-clinician communication following nephrectomy in renal cell carcinoma: Development, content validation and pilot testing of a conversation aid tool.
Patient Educ Couns 2021; 104(1): 99-108;
Bentley S, Johnson C, Exall E, Brohan E, Lawrance R, Bennett B, Bargo D, Zanotti G, Staehler M, Stewart GD

Picotamide inhibits a wide spectrum of agonist-induced smooth muscle contractions in porcine renal interlobar and coronary arteries.
Pharmacol Res Perspect 2021; 9(3):
Li B, Huang R, Wang R, Liu Y, Stief CG, Hennenberg M

A matter of size? Health-related quality of life after radical prostatectomy for patients with giant prostates.
Prostate 2021; 81(8): 443-451;
Westhofen T, Buchner A, Schlenker B, Becker A, Chaloupka M, Bischoff R, Stief CG, Kretschmer A

Influence of pelvic lymph node dissection and node-positive disease on biochemical recurrence, secondary treatment, and survival after radical prostatectomy in men with prostate cancer.
Prostate 2021; 81(2): 102-108;
Washington SL, Cowan JE, Herlemann A, Zuniga KB, Masic S, Nguyen HG, Carroll PR

Inhibition of human prostate stromal cell growth and smooth muscle contraction by thalidomide: A novel remedy in LUTS?
Prostate 2021;
Tamalunas A, Sauckel C, Ciotkowska A, Rutz B, Wang R, Huang R, Li B, Stief CG, Gratzke C, Hennenberg M

Active surveillance in intermediate-risk prostate cancer with PSA 10-20 ng/mL: pathological outcome analysis of a population-level database.
Prostate Cancer Prostatic Dis 2021;
Lonergan PE, Jeong CW, Washington SL, Herlemann A, Gomez SL, Carroll PR, Cooperberg MR

Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer.
Radiat Oncol 2021; 16(1);
Rogowski P, Trapp C, von Bestenbostel R, Schmidt-Hegemann NS, Shi R, Ilhan H, Kretschmer A, Stief C, Ganswindt U, Belka C, Li M

Radiotherapy of oligometastatic prostate cancer: a systematic review.
Radiat Oncol 2021; 16(1)
Rogowski P, Roach M, Schmidt-Hegemann NS, Trapp C, von Bestenbostel R, Shi R, Buchner A, Stief C, Belka C, Li M

Postoperative change in Gleason score of prostate cancer in fusion targeted biopsy: a matched pair analysis.
Scand J Urol 2021; 55(1): 27-32;
Apfelbeck M, Tritschler S, Clevert DA, Buchner A, Chaloupka M, Kretschmer A, Herlemann A, Stief C, Schlenker B

Towards reliable diagnostics of prostate cancer via breath.
Sci Rep 2021; 11(1):
Maiti KS, Fill E, Strittmatter F, Volz Y, Sroka R, Apolonski A

How the COVID-19 Pandemic Affects Sexual Behavior of Hetero-, Homo-, and Bisexual Males in Germany.
Sex Med 2021; 9(4);
Mumm JN, Vilsmaier T, Schuetz JM, Rodler S, Zati Zehni A, Bauer RM, Staehler M, Stief CG, Batz F

RAS-NOTECHS: validity and reliability of a tool for measuring non-technical skills in robotic-assisted surgery settings.
Surg Endosc 2021;
Schreyer J, Koch A, Herlemann A, Becker A, Schlenker B, Catchpole K, Weigl M

Choosing a Specialist: An Explanatory Study of Factors Influencing Patients in Choosing a Urologist.
Urol Int 2021; (): 1-8;
Tamalunas A, Buchner A, Hennenberg M, Stadelmeier LF, Höhn H, Vilsmaier T, Mumm ML, Kolben T, Stief CG, Mumm JN

Does Pandemic Anxiety Affect Urology Health Care Workers?
Urol Int 2021; 105(3-4): 192-198;
Apfelbeck M, Staehler M, Rodler S, Stredele R, Chaloupka M, Mumm JN, Buchner A, Stief C, Casuscelli J

Five-Year Results of a Prospective Multicenter Trial: AdVance XP for Postprostatectomy-Incontinence in Patients with Favorable Prognostic Factors.
Urol Int 2021; (): 1-7;
Mumm JN, Klehr B, Rodler S, Kretschmer A, Vilsmaier T, Westhofen T, Chaloupka M, Schulz GB, Gozzi C, Rehder P, May F, Homberg R, Stief CG, Grabbert M, Bauer RM

Listening to Music during Outpatient Cystoscopy Reduces Pain and Anxiety and Increases Satisfaction: Results from a Prospective Randomized Study.
Urol Int 2021; 105(9-10): 792-798;
Mumm JN, Eismann L, Rodler S, Vilsmaier T, Zehni AZ, Apfelbeck M, Pfitzinger PL, Volz Y, Chaloupka M, Bauer RM, Stief CG, Staehler M

Mapping Telemedicine in German Private Practice Urological Care: Implications for Transitioning beyond the COVID-19 Pandemic.
Urol Int 2021; (): 1-7;
Rodler S, Schütz JM, Styn A, Weinhold P, Casucelli J, Eismann L, Bauer RM, Staehler M, Stief C, Buchner A, Mumm JN

Multiparametric MRI Lesion Classified as Prostate Imaging-Reporting and Data System 5 but Histopathologically Described as Benign: A Case Report and Review of Literature.
Urol Int 2021; (): 1-5;
Apfelbeck M, Schlenker B, Chaloupka M, Stief CG, Clevert DA

The Impact of Fluorescence in situ Hybridization on the Staging of Upper Tract Urothelial Carcinoma.
Urol Int 2021; (): 1-6;
Eismann L, Mumm JN, Bohn L, Wülfing C, Knüchel-Clarke R, Casuscelli J, Waidelich R, Stief CG, Schlenker B, Rodler S

Dynamic contrast-enhanced CT-derived blood flow measurements enable early prediction of long term outcome in metastatic renal cell cancer patients on antiangiogenic treatment.
Urol Oncol 2021;
Spek A, Graser A, Casuscelli J, Szabados B, Rodler S, Marcon J, Stief C, Staehler M

PD-L1 expression in bladder cancer: Which scoring algorithm in what tissue?
Urol Oncol 2021;
Schulz GB, Todorova R, Braunschweig T, Rodler S, Volz Y, Eismann L, Pfitzinger P, Jokisch F, Buchner A, Stief C, Mayr D, Casuscelli J

Radical cystectomy for locally advanced urothelial carcinoma of the urinary bladder: Health-related quality of life, oncological outcomes and predictors for survival.
Urol Oncol 2021; 39(5): 299.e15-299.e21
Volz Y, Grimm T, Ormanns S, Eismann L, Pfitzinger PL, Jokisch JF, Schulz G, Casuscelli J, Schlenker B, Karl A, Stief CG, Kretschmer A

Single center retrospective analysis of fifty-two prostate cancer patients with customized MR-guided transurethral ultrasound ablation (TULSA).
Urol Oncol 2021;
Lumiani A, Samun D, Sroka R, Muschter R

[Alloplastic material in the treatment of urinary incontinence].
Urologe A 2021; 60(6): 706-713;
Grabbert M, Bauer RM

[Aspects of perioperative management].
Urologe A 2021; 60(2): 149-150;
Haferkamp A, Stief CG

[Diagnostic markers in urology].
Urologe A 2021;
Hupe MC, Hempel MC, Rodler S, Frantzi M, Mischak H, Merseburger AS, Stief CG, Chaloupka M

[Enhanced Recovery After Surgery (ERAS®) after radical cystectomy-current data].
Urologe A 2021; 60(2): 162-168;
Schulz GB, Volz Y, Jokisch F, Casuscelli J, Eismann L, Pfitzinger P, Stief CG, Schlenker B

[Incontinence surgery-quality criteria and structured follow-up].
Urologe A 2021; 60(2): 178-185;
Grabbert M, Gratzke C, Khoder WY, Katzenwadel A, Bauer RM

[Mentoring in urological postgraduate training : Use of a competence matrix for the evaluation of results].
Urologe A 2021; 60(2): 203-211;
Necknig U, Leyh H, Gernhold L, Waidelich R, V Ostau N, Kunisch R, Kiesewetter J, Weidenbusch M

[Molecular diagnostics of bladder cancer-practical ramifications].
Urologe A 2021; 60(10): 1349-1358;
Schulz GB, Stief CG, Saar M, Vögeli TA, Todenhöfer T, Knüchel R, Gaisa NT

[Practical skills training : How suitable is Peyton's four-step approach for residents in urology?]
Urologe A 2021; 60(4): 475-483;
Necknig U, Buchner A, Leyh H, Pycha A, Borowitz R, Eder E, Frei C, Keller S, von Ostau N, Rüsseler M, Sterz J

[Stress urinary incontinence in men].
Urologe A 2021; 60(1): 109-118;
Bauer RM, Ameli G, Schultz-Lampel D, Rutkowski MCE

[Systemic treatment of bladder cancer].
Urologe A 2021; 60(2): 247-258;
Tamalunas A, Schulz GB, Rodler S, Apfelbeck M, Stief CG, Casuscelli J

[Viral infections in urology].
Urologe A 2021; 60(9): 1150-1158;
Magistro G, Pilatz A, Schneede P, Schneidewind L, Wagenlehner F

Enucleation vs. Resection: A matched-pair analysis of TURP, HoLEP and bipolar TUEP in medium-sized prostates.
Urology 2021;
Magistro G, Schott M, Keller P, Tamalunas A, Atzler M, Stief CG, Westhofen T

Spinal Versus General Anesthesia for Holmium Laser Enucleation of the Prostate of High-risk Patients - A Propensity-score-matched-analysis.
Urology 2021
Westhofen T, Schott M, Keller P, Tamalunas A, Atzler M, Ebner B, Schultheiß M, Damm A, Kowalski C, Stief CG, Magistro G

Adherence to guidelines in the management of urolithiasis: are there differences among distinct patient care settings?
World J Urol 2021;
Eismann L, Kretschmer A, Bader MJ, Kess S, Stief CG, Strittmatter F

COVID-19 and financial toxicity in patients with renal cell carcinoma.
World J Urol 2021; 39(7): 2559-2565;
Staehler MD, Battle DJ, Bergerot CD, Pal SK, Penson DF

Comparison of stone elimination capacity and drilling speed of endoscopic clearance lithotripsy devices.
World J Urol 2021; 39(2): 563-569;
Bader MJ, Eisel M, Strittmatter F, Nagele U, Stief CG, Pongratz T, Sroka R, Training and Research in Urological Surgery and Technology (T.R.U.S.T.)-Group

Contemporary role of palliative cystoprostatectomy or pelvic exenteration in advanced symptomatic prostate cancer.
World J Urol 2021; 39(7): 2483-2490;
Surcel C, Mirvald C, Tsaur I, Borgmann H, Heidegger I, Labanaris AP, Sinescu I, Tilki D, Ploussard G, Briganti A, Montorsi F, Mathieu R, Valerio M, Jinga V, Badescu D, Radavoi D, van den Bergh RCN, Gandaglia G, Kretschmer A, as part of the EAU-YAU PCa Working Party

Impact of previous transurethral prostate surgery on health-related quality of life after radical prostatectomy: Does the interval between surgeries matter?
World J Urol 2021; 39(5): 1431-1438;
Chaloupka M, Figura F, Weinhold P, Jokisch F, Westhofen T, Pfitzinger P, Bischoff R, Magistro G, Strittmatter F, Becker A, Ormanns S, Schlenker B, Buchner A, Stief CG, Kretschmer A

Polyethylene glycol-coated collagen patch (hemopatch®) in open partial nephrectomy.
World J Urol 2021;
Staehler M, Rodler S, Schott M, Casuscelli J, Stief C, Spek A, Schlenker B

Prognostic value of pretreatment inflammatory markers in variant histologies of the bladder: is inflammation linked to survival after radical cystectomy?
World J Urol 2021; 39(7): 2537-2543;
Rodler S, Buchner A, Ledderose ST, Eismann L, Volz Y, Pfitzinger P, Kretschmer A, Schulz GB, Karl A, Schlenker B, Stief CG, Jokisch F

The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaboration.
World J Urol 2021; 39(2): 443-451;
Afferi L, Zamboni S, Karnes RJ, Roghmann F, Sargos P, Montorsi F, Briganti A, Gallina A, Mattei A, Schulz GB, Hendricksen K, Voskuilen CS, Rink M, Poyet C, De Cobelli O, di Trapani E, Simeone C, Soligo M, Simone G, Tuderti G, Alvarez-Maestro M, Martínez-Piñeiro L, Aziz A, Shariat SF, Abufaraj M, Xylinas E, Moschini M, European Association of Urology-Young Academic Urologists (EAU-YAU), Urothelial Carcinoma Working Group

The natural course of urinalysis after urinary diversion.
World J Urol 2021; 39(5): 1559-1567;
Magistro G, Zimmermann L, Bischoff R, Westhofen T, Grimm T, Schlenker B, Stief CG, Marcon J

The significance of a high preoperative PSA level for the detection of incidental prostate cancer in LUTS patients with large prostates.
World J Urol 2021; 39(5): 1481-1487;
Magistro G, Keller P, Westhofen T, Schott M, Tamalunas A, Weinhold P, Stief CG